A
Avivomed
Developing and commercializing next generation neuromodulaton technology platforms to treat patients suffering from chronic diseases
About Avivomed
Avivomed is a medical device company that develops neuromodulation therapies for chronic diseases. The company is focused on creating minimally invasive treatments that can improve the quality of life for patients with unmet clinical needs.
Avivomed's main product is a neuromodulation platform that uses electrical stimulation to modulate the nervous system. This technology can be used to treat a variety of conditions, including chronic pain, overactive bladder, and fecal incontinence. The company is currently in the development stage and has not yet commercialized its products.
Avivomed is a privately held company that was founded in 2021. The company has raised $3.2 million in Series A financing and is backed by a number of venture capital firms.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Employees
- 18
- Open positions
- None listed
- Dealroom signal
- 76.3/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- medical implants, Neuromodulation and Neurostimulation, Chronic Disease, Hard Tech, DT and LS, science-based
- Technology
- Deep Tech
- Client focus
- B2B
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Dec 2021 | $32M | $128M | Undisclosed | ↗ |
Growth signals
Latest recorded traffic for Avivomed is 1K monthly website visits, up 212.5% over the last three months. Avivomed's team declined 10% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Avivomed in the Roseville ecosystem
The Avivomed office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Other known investors2 additional known investors
F-Prime
WakeMed
Source: Dealroom Talent Intelligence.
See Avivomed’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.










